1-1 of 1
Holger J. Moller, MD, PHD
Close
Save search
Sort by
Journal Articles

Impaired CD163 Mediated Hemoglobin-Scavenging and Hemolytic Crisis in Patients Treated with CD33 Targeted Chemotherapy (Gemtuzumab Ozogamicin, Mylotarg™).

Free
Maciej B. Maniecki, MHSc, Henrik Hasle, MD, PHD, Lennart Friis-Hansen, MD, PHD, Birgitte Lausen, MD, PHD, Ove J. Nielsen, MD, PHD, Knud Bendix, MD, PHD, Soren K. Moestrup, MD, PHD, Holger J. Moller, MD, PHD
Journal: Blood
Blood (2007) 110 (11): 3684.
https://doi.org/10.1182/blood.V110.11.3684.3684
Published: 2007